Cocaine

ADVERTISEMENT

Identification

Molecular formula
C17H21NO4
CAS Number
50-36-2
IUPAC Name
methyl (1R,2R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
Molecular Weight
303.35g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2160g/cm3
Interesting facts

Interesting Facts about Methyl (1R,2R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate

This fascinating compound, known as methyl (1R,2R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate, belongs to a unique class of bicyclic compounds that contain both azabicyclic and carboxylate functionalities. Here are some intriguing aspects worth noting:

  • Structural Complexity: The structural arrangement of this compound showcases a bicyclic system, which poses interesting stereochemical challenges. The specific stereochemistry defined by the (1R,2R,5R) configuration is essential for determining the compound's reactivity and bioactivity.
  • Potential Applications: Compounds of this type have potential applications in drug discovery. Given the bicyclic framework, they may serve as scaffolds in the development of new pharmaceutical agents.
  • Plant Alkaloid Connection: The framework of the compound recalls some alkaloids derived from plants, which often exhibit significant biological activity, including analgesic and anti-inflammatory properties.
  • Research Opportunities: The complexity of this compound opens numerous avenues for research, especially in the fields of medicinal chemistry and organic synthesis. Researchers are often eager to explore the pharmacological properties that these intricate structures might possess.

In summary, the methyl (1R,2R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate is not just a compound of interest for its chemical properties, but also for its potential impact on medicinal chemistry and pharmacology. The synthesis of such compounds can provide insights into advanced chemical strategies and the quest for innovative pharmaceuticals.

ADVERTISEMENT